{"id":"tp-54959","type":"article-newspaper","title":"PharmaCyte Biotech Board Approves 1-for-19 Reverse Stock Split","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/54959","datePublished":"2026-11-12T05:20:17.000Z","dateModified":"2026-11-12T05:20:17.000Z","language":"en","abstract":"The split is intended to help the company meet Nasdaq's minimum bid price requirement for continued listing. Split-adjusted trading is scheduled to begin Nov. 13.","section":"Business","references":[]}